Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke
Author(s) -
Bruce Campbell,
Peter Mitchell,
Leonid Churilov,
Nawaf Yassi,
Timothy Kleinig,
Richard Dowling,
Bernard Yan,
Steven Bush,
Helen M. Dewey,
Vincent Thijs,
Rebecca Scroop,
Marion Simpson,
Mark Brooks,
Hamed Asadi,
Teddy Y. Wu,
Darshan Shah,
Tissa Wijeratne,
Timothy Ang,
Ferdinand Miteff,
Christopher Levi,
Edrich Rodrigues,
Henry Zhao,
Patrick Salvaris,
Carlos García-Esperón,
Peter Bailey,
Henry E. Rice,
Laetitia de Villiers,
Helen Brown,
Kendal Redmond,
David Leggett,
John Fink,
Wayne Collecutt,
Andrew Wong,
Claire Muller,
Alan Coulthard,
Ken Mitchell,
John Clouston,
Kate Mahady,
Deborah Field,
Henry Ma,
Thanh G. Phan,
Winston Chong,
Ronil V. Chandra,
LeeAnne Slater,
Martín Krause,
Timothy Harrington,
Kenneth Faulder,
Brendan Steinfort,
Christopher F. Bladin,
Gagan Sharma,
Patricia Desmond,
Mark Parsons,
Geoffrey A. Donnan,
Stephen M. Davis
Publication year - 2018
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1716405
Subject(s) - medicine , tenecteplase , modified rankin scale , thrombolysis , fibrinolytic agent , stroke (engine) , intracerebral hemorrhage , tissue plasminogen activator , confidence interval , anesthesia , surgery , ischemia , subarachnoid hemorrhage , ischemic stroke , myocardial infarction , mechanical engineering , engineering
Intravenous infusion of alteplase is used for thrombolysis before endovascular thrombectomy for ischemic stroke. Tenecteplase, which is more fibrin-specific and has longer activity than alteplase, is given as a bolus and may increase the incidence of vascular reperfusion.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom